The information found here was obtained from Erin T.
A study to evaluate delivery of Natalizumab (Tysabri®)
Study Rationale: While other Multiple Sclerosis medications can be administered at home, Natalizumab is given through IV at infusion centers. This can be costly and inconvenient to patients, especially if there is not an infusion center nearby.
Study Objective: The objective of the study is to determine if Natalizumab can be given by subcutaneous (SC) injection (under the skin). This will be accomplished through laboratory blood work, clinical assessments, and MRI scans.
Study Description: The study is sponsored by Biogen Idec. Neurologist Dr. Ronald Murray will oversee all study activities at IMMUNOe Health Centers.
New participants will be assigned to either Group D or Group E (in white):
(Click this link to continue):
######################
If you know anybody with, or affected by Multiple Sclerosis (MS), please ask them to register at my website: http://www.msviewsandnews.org- Once registered, the person will then receive our weekly MS related e-newsletter and have access to thousands of MS related articles. Also, please view our MS Blog (http://wwwmsviewsandrelatednews.blogspot.com/).
Help me to empower those affected by MS. After all, "Knowledge is Power".
######################
Comments
To add a comment to the original post, click here.
You must be signed in to post a comment.
Sign in nowThere are no comments for this post.